Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001719897 | SCV000167478 | likely benign | not provided | 2020-10-21 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000310705 | SCV000377770 | likely benign | Timothy syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000365427 | SCV000377771 | likely benign | Brugada syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000460955 | SCV000562914 | likely benign | Long QT syndrome | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000124069 | SCV001442775 | benign | not specified | 2020-10-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001719897 | SCV001961327 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | CACNA1C: BP4, BP7 |
Ambry Genetics | RCV002444585 | SCV002680624 | likely benign | Cardiovascular phenotype | 2017-12-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV001719897 | SCV003799509 | benign | not provided | 2022-03-28 | criteria provided, single submitter | clinical testing |